期刊文献+

转染融合基因的DC抗肿瘤免疫效应

Specific Anti-tumor Immunological Effect by Dendritic Cell Transfected with GM-ΔSur Gene
下载PDF
导出
摘要 目的研究转染融合基因(GM-CSF-survivin GM-ΔSur)的树突状细胞(DC)在体外诱导高效而特异的抗肿瘤免疫效应。方法用jetPEITM-Macrophage转染体系,将构建的GM-ΔSur融合基因转染入DC,用流式细胞仪检测DC的表面分子HLA-DR、CD83、CD80、CD86表达的高低;用LDH法测定转染融合基因的DC诱导特异性细胞毒性T淋巴细胞(CTLs)杀伤肿瘤细胞(HT-29和OVCAR-3)的能力。结果转染融合基因的DC细胞中可检测到GM-ΔSur融合蛋白的表达;DC表面高表达HLA-DR、CD83、CD80、CD86;PHA/rhIL-2长期培养(21d)的T细胞CD8+比例明显增加;转染融合基因的DC对HT-29肿瘤细胞的杀伤率显著高于未修饰的DC的杀伤率。结论GM-ΔSur基因转染修饰的DC能选择性诱导MHC-I类分子限制的CTL的特异性,显著提高DC的抗原提呈功能和诱导高效而特异的抗肿瘤免疫效应。 Objective To study the specific anti-tumor immunological effects induced by dendritic cells transfected with GM-CSF gene and survivin gene(GM-ASur) in vitro. Methods pcDNA 3. 1 plasmid containing GM-ASur fusion gene was constructed and was transfected into dendritic cells by jetPEI^TM- Mcrophage transfected kit; cellular surface phenotype such as CD1a, CD80, CD86, CD83 were detected by FACS; The specific cytotoxicity of induced human cytotoxic T lymphocyte (CTLs) to tumor cells was detected with LDH assay. Results GM-ΔSur expression was detected in DC cells; High-level expression of HLA-DR, CD1a, CD80, CD86, CD83 were found in transeneed DC cells; The ratio of CD8^+ cells cultured with PHA/rhIL-2 were largely increased. The lyse rate of induced CTL cells to HT-29 cell were much higher than those of blank DC cells. Conclusion GM-ΔSur gene modified DC cells could induce MHC- Ⅰ specific cytotoxic T lymphocytes and strikingly raised DC cell' s antigen present function and could induce high effective and specific anti-cancer immunological effect.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第9期647-650,736,共5页 Cancer Research on Prevention and Treatment
基金 四川省科技厅应用基础资助项目(03JY029-103-2)
关键词 肿瘤 树突状细胞 融合基因 CTL SURVIVIN Tumor Dendritic cell Fusion Gene CTL survivin
  • 相关文献

参考文献19

  • 1Caldas H,Jiang Y,Holloway MP,et al.Survivin splice variants regulate the balance between proliferation and cell death[J].Oncogene,2005,24(12):1994-2007.
  • 2Dallal R M,Lotze M T.The dendritic cell and human cancer vaccines[J].Curr Opin Immunol,2000,12(5):583-588.
  • 3Cao X,Zhang W,Wang J,et al.Therapy of established tumor with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating genetically modified dendritic cell[J].Immunology,1999,97(4):616-625.
  • 4Beatrice S T,Erwin S S,Thomas G B,et al.Rapid induction of tumor-specific type I T helper cells in metastatic melanoma patients by vaccination with mature,cryopreserved,peptide-load monocyte-derived dendritic cells[J].J Exp Med,2002,195(10):1279-1288.
  • 5Zeis M,Siegel S,Wagner A,et al.Generation of cytotoxic resposes in mice and human individuals against hematological malignancies using surviving-RNA transfected dendritic cells[J].J Immunol,2003,170(11):5391-5397.
  • 6Heiser A,Maurice M A,Yance y D R,et al.Human dendritic cells transfected with renal tumou RNA stimulate polyclonal T-Cell responses against antigens expressed by primary and metastatic tumous[J].Cancer Res,2001,61(8):3388-3393.
  • 7Altieri DC.Survivin,versatile modulation of cell division and apoptosis in cancer[J].Oncogene,2003,22(53):8581-8589.
  • 8O'Connor DS,Schechner JS,Adida C,et al.Altieri DC Control of apoptosis during angiogenesis by surviving expression in endothelial cells[J].Am J Pathol,2000,156(2):393-398.
  • 9Song Z,Yao X,Wu M.Direct interaction between surviving and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis[J].J Biol Chem,2003,278(25):23130-23140.
  • 10Asanuma K,Moriai R,Yajima T,et al.Survivin as a radio-resistance factor in pancreatic cancer[J].Jap J Cancer Res,2000,91(11):1204-1209.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部